Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviSelf-StudyTreatment of Key Populations and Unique Situations
Treatment of Key Populations and Unique Situations
Sign In or Register to get started
Treatment of Key Populations and Unique Situations
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 6 Overview
Perinatal HCV Transmission - 0%Topic 1
BackgroundActivities- 0%Topic 2
HCV Screening During PregnancyActivities- 0%Topic 3
Factors Associated with HCV Perinatal TransmissionActivities- 0%Topic 4
Impact of Chronic HCV Infection on PregnancyActivities- 0%Topic 5
Effect of Pregnancy on Chronic HCVActivities- 0%Topic 6
Interventions to Prevent Mother-to-Child Transmission of HCVActivities- 0%Topic 7
Safety of HCV Treatment During Pregnancy and BreastfeedingActivities- 0%Topic 8
Monitoring of Pregnant Women with HCVPerinatal HCV Transmission Overview
About this Lesson
Last Updated: January 27th, 2024CNE/CME Continuing Education
This lesson qualifies for:- 1 CME AMA PRA Category 1 Credit™, or
- 1 CNE contact hour and 1 CE contact hour (does NOT qualify for pharmacology CE for advanced practice nurses)
CNE and CME Origination: February 15th, 2021CNE and CME Review: February 14th, 2024CNE and CME Expiration: February 13th, 2027 (4th Edition)
View CE NoticesSteps to Acquire CE for this Lesson:
1Quiz
Score 80%+2Give Feedback
Complete survey3Print CE Certificate
Obtain proof of CE4th Edition
This is a substantial revision of the original Lesson. The previous edition was titled Perinatal HCV Transmission and available until February 14th, 2024.Learning Objectives
- Describe the current guidelines for HCV screening in pregnant women
- Identify the risk of mother-to-child transmission of HCV and factors associated with increased risk of transmission
- Summarize the impact of HCV on pregnancy outcomes
- Describe interventions and/or prophylactic measures to reduce the risk of mother-to-child transmission of HCV
- List recommendations for HCV testing and management in infants born to mothers with HCV.
Lesson Contributors
Authors
Maria A. Corcorran, MD, MPHMaria A. Corcorran, MD, MPH
Assistant Professor
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneReviewers
David H. Spach, MDDavid H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of WashingtonDisclosures:NoneLesson Plan
Quick Reference View
A single document for easy access to every topic in the self-study modules.
PDF version also available.
No sign-in required for Quick Reference
Funded byCenters for Disease Control and Prevention Cooperative Agreement (CDC-RFA-PS21-2105)Created at University of WashingtonPart of IDEA PlatformCME provided byUniversity of Alabama BirminghamCNE provided byUniversity of Washington School of NursingCopyright © 2024 Hepatitis C OnlineSince you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhcvc-master-c8843673-2024-11-13-205624 - 0%Topic 2